Work

Evaluating the extent of reusability of CYP2C19 genotype data among patients genotyped for antiplatelet therapy selection

Year: 2020

Type: article

Study design: Observational Study

Source: Genetics in Medicine

Authors: Amber L. Beitelshees, James M. Stevenson, Nihal El Rouby, Chrisly Dillon, Philip E. Empey, Elliot M. Fielstein, Julie A. Johnson, Nita A. Limdi, Henry H. Ong, Francesco Franchi, Dominick J. Angiolillo, Joshua F. Peterson, Marc B. Rosenman, Todd C. Skaar, Sony Tuteja, Larisa H. Cavallari

Institutions: University of Maryland, Baltimore, University of Pittsburgh, University of Florida, University of Cincinnati, University of Alabama at Birmingham, UAB Medicine, Vanderbilt University, Vanderbilt University Medical Center, University of Florida Health Science Center, Northwestern University, Lurie Children's Hospital, Indiana University School of Medicine, Indiana University Indianapolis, University of Pennsylvania

Language: English

Topic: Pharmacogenetics and Drug Metabolism

Subfield: Pharmacology

Field: Pharmacology, Toxicology and Pharmaceutics

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: bronze

Funders: National Institutes of Health, National Heart, Lung, and Blood Institute, National Human Genome Research Institute, National Center for Advancing Translational Sciences

Awards: G1015979621, G1638686622, G1725353665, G2596056898, Center for Clinical and Translational Science, G2956969645, UF Clinical and Translational Science Award, G4660110595, G4707906123, Genomic Diagnosis and Individualized Therapy of Highly Penetrant Genetic Diabetes, G6854337074, G884570035

OpenAlex ID: W4211075359

FWCI: 1.559

Cites: 15

Cited by: 10

Related to: 10